All One Health Content – Page 160
-
NewsHeat-loving marine bacteria can help detoxify asbestos
Researchers have shown that extremophilic bacteria from high temperature marine environments can be used to reduce the toxicity of asbestos.
-
NewsTracking AMR in E. coli isolated from swine reveals worrying trends
Scientists have carried out the first surveillance study in the US that looks at antimicrobial resistance in E. coli from swine at slaughter.
-
NewsResearchers use 3D models to investigate movement of Helicobacter pylori
Scientists have created a 3D model of Helicobacter pylori to better understand its movement, hoping to crack the code governing the organism’s motility and develop alternative treatments for infections, such as strengthening the gastric mucus barrier that stands against the bacteria.
-
NewsResistant Candida auris on rise in Germany, setting off alarm signals
The number of cases of Candida auris has increased in Germany in recent years, adding to outbreaks worldwide, a new study has revealed.
-
NewsTraditional medicine plant could combat drug-resistant malaria
Researchers have identified compounds in the leaves of a particular medicinal Labrador tea plant used throughout the First Nations of Nunavik, Canada, and demonstrated that one of them has activity against the parasite responsible for malaria.
-
NewsSecond gene implicated in malaria chloroquine resistance evolution
How malaria parasites evolved to evade a major antimalarial drug has long been thought to involve only one key gene. Now, scientists have shown a second key gene is also involved in malaria’s resistance to the drug chloroquine.
-
NewsAI strategies already boosting sepsis cure rate
An artificial intelligence developed at TU Wien (Vienna) can suggest appropriate treatment steps in cases of blood poisoning.
-
NewsBacteria evolve antibiotic resistance quickly by rejigging pumps
Bacteria can rapidly evolve resistance to antibiotics by adapting special pumps to flush them out of their cells, according to new research from the Quadram Institute and University of East Anglia.
-
NewsPostal HPV kits boost cervical screening uptake
At-home high-risk human papillomavirus (hrHPV) sampling kits can help increase cervical cancer screening among under-screened women from low-income backgrounds, according to findings from a US-based clinical trial.
-
NewsInter-species interactions may stymie antibiotics
A new study suggests that between-species interactions within the gut microbiome may impact the efficacy of antibiotics aimed at treating C. difficile infections.
-
NewsEye drops cause infection long before CDC warning
A patient was diagnosed with a dangerous Pseudomonas aeruginosa eye infection caused by contaminated eye drops, months before the CDC issued warnings against using the product.
-
NewsTobacco plant engineered to act as drug factory
Researchers have engineered a close relative of tobacco, Nicotiana benthamiana, to churn out peptides with antibiotic activity against some of the nastiest pathogens known to medicine.
-
NewsMeet Ginger: the gene-edited calf resistant to BVDV
Scientists introduce Ginger, the first gene-edited calf with reduced susceptibility to a major viral pathogen.
-
NewsProtein may pave way to eliminating HIV latency
Researchers have identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor that shuts down viral protein production and helps virus-infected cells to escape from anti-HIV therapy and immune responses.
-
NewsSleep supplement impairs action of gut microbiota
Despite its antioxidant effects and role in regulating sleep cycles, tests show melatonin can worsen inflammation of the intestine and impair the action of gut microbiota.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsFaecal beads target serious intestinal infections
Researchers have developed small beads to be taken orally, which could radically improve the administration of faecal microbiota transplantation to treat Clostridioides difficile infection.
-
NewsBenchtop model lays bare secrets of gut microbiome
A benchtop model of the human gut (MiGut) has been developed to allow the interaction of drugs, nutrition, prebiotics, and live biotherapeutics with the gut microbiome to be studied in greater depth than ever before.
-
NewsDesulfovibrio implicated in Parkinson’s disease
Researchers have demonstrated that certain strains of Desulfovibrio bacteria are the likely cause of Parkinson’s disease in most cases.
-
NewsTumour bacteria can trigger anticancer response
A novel approach to treating cancer uses bacteria that naturally reside within tumours to trigger a powerful anticancer immune response.